CND Neurological disorder drug Targets 2017 Study: Neurological Aspects of Medical Use of Cannabidiol.
Neurotherapeutics 2015 Abstract: Neuroprotective properties of cannabigerol in Huntington’s disease: studies in R6/2 mice and 3-nitropropionate-lesioned mice.
NCBI 2012 Abstract: Cannabinoids: Novel medicines for the treatment of Huntington’s disease.
ACS Chem Neuroscience 2012 Study: Sativex-like combination of phytocannabinoids is neuroprotective in malonate-lesioned rats, an inflammatory model of Huntington’s disease: role of CB1 and CB2 receptors.
NCBI 2011 Abstract: Prospects for cannabinoid therapies in basal ganglia disorders.
NCBI 2007 Abstract: Cannabinoids in health and disease